Over the last 12 months, Dexcom insiders reported no purchases and 9 sales totaling $7.5M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | FOLETTA MARK GD | ▼ Sale | 4,000 | $82.66 | $331K | -7.6% | plan · 2 tranches · indirect |
| Jul 20, 2026 | SAYER KEVIN RExecutive Chair · O·D | ▼ Sale | 26,756 | $76.32 | $2.0M | -7.5% | plan |
| Jul 15, 2026 | Brown Michael JonEVP Chief Legal Compliance Off · O | ▼ Sale | 1,700 | $74.42 | $127K | -1.6% | plan |
| Jul 6, 2026 | SAYER KEVIN RExecutive Chair · O·D | ▼ Sale | 26,756 | $72 | $1.9M | -7% | plan |
| Jun 15, 2026 | Brown Michael JonEVP Chief Legal Compliance Off · O | ▼ Sale | 1,700 | $75.55 | $128K | -1.6% | plan |
| Jun 15, 2026 | FOLETTA MARK GD | ▼ Sale | 4,000 | $74.13 | $297K | -7% | plan · 2 tranches · indirect |
| Jun 4, 2026 | Coleman JonEVP, Chief Commercial Officer · O | ▼ Sale | 4,911 | $74.13 | $364K | -4.9% | plan |
| Jun 3, 2026 | Coleman JonEVP, Chief Commercial Officer · O | ▼ Sale | 4,912 | $73 | $359K | -4.7% | plan |
| May 21, 2026 | SAYER KEVIN RExecutive Chair · O·D | ▼ Sale | 26,759 | $72 | $1.9M | -6.5% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DXCM feed.